Coffee Bioequivalence Trial

NCT06758531 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Liver Functions
Bioequivalence
Cardiovascular Risk
Cardiometabolic Risk Markers

Interventions

DIETARY_SUPPLEMENT: Instant coffee given as a drink
DIETARY_SUPPLEMENT: Coffee given in a tablet form
DIETARY_SUPPLEMENT: Control (placebo)

Sponsor

University of Reading